WASHINGTON, June 5, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that it will participate at the following upcoming investor conferences in June 2017.
The Jefferies 2017 Global Healthcare Conference in New York City on Wednesday, June 7, 2017. A corporate presentation is scheduled for 2:00 p.m. Eastern Time.
The JMP Securities Life Sciences Conference in New York City on Tuesday, June 20, 2017.
The corporate presentation given at the Jefferies Healthcare Conference will be available live on Vanda's corporate website, where they also will be archived for 30 days. To access the presentation, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentation.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.
Company Contact:Jim KellyExecutive Vice President and Chief Financial OfficerVanda Pharmaceuticals Inc.(202) [email protected]
Advertisement
The Jefferies 2017 Global Healthcare Conference in New York City on Wednesday, June 7, 2017. A corporate presentation is scheduled for 2:00 p.m. Eastern Time.
Advertisement
The JMP Securities Life Sciences Conference in New York City on Tuesday, June 20, 2017.
The corporate presentation given at the Jefferies Healthcare Conference will be available live on Vanda's corporate website, where they also will be archived for 30 days. To access the presentation, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentation.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.
Company Contact:Jim KellyExecutive Vice President and Chief Financial OfficerVanda Pharmaceuticals Inc.(202) [email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-june-2017-investor-conferences-300468729.html
SOURCE Vanda Pharmaceuticals Inc.
